Rhinosinusitis Clinical Trials in Birmingham, Alabama
5 recruitingBirmingham, Alabama
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Eli Lilly and Company510 enrolled202 locationsNCT06338995
Recruiting
Not Applicable
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Airiver Medical, Inc.300 enrolled8 locationsNCT07290140
Recruiting
Phase 3
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps
Sanofi210 enrolled112 locationsNCT06834360
Recruiting
Early Phase 1
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
Chronic Rhinosinusitis (Diagnosis)
University of Alabama at Birmingham20 enrolled1 locationNCT03439865
Recruiting
Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis
Rhinosinusitis
University of Alabama at Birmingham20 enrolled1 locationNCT02038166